Moleculin Biotech, Inc. Financing Cash Flow
Moleculin Biotech, Inc. (MBRX) reported Financing Cash Flow of $11.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.61M, a 33.38% decline year-over-year.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $7.61M, a 4.84% decline year-over-year.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $7.49M, a 748600.00% increase year-over-year.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $6.38M, a 36.83% increase year-over-year.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $27.28M, a 488.65% increase from fiscal 2024.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $4.63M, a 11.93% increase from fiscal 2023.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $4.14M.
- Moleculin Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$23.00K, a 100.03% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $11.22M 10-Q · filed 2026-08-13 | $18.71M derived: sum of 3 quarters · filed 2026-08-13 | $25.09M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $7.61M 10-Q · filed 2026-05-14 | $15.10M derived: sum of 2 quarters · filed 2026-05-14 | $21.47M derived: sum of 3 quarters · filed 2026-05-14 | $26.90M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $13.86M derived: sum of 2 quarters · filed 2026-03-18 | $19.29M derived: sum of 3 quarters · filed 2026-08-13 | $27.28M 10-K · filed 2026-03-18 | |
| 2025-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.80M derived: sum of 2 quarters · filed 2026-08-13 | $19.80M 10-Q · filed 2025-11-13 | $19.80M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.42M 10-Q · filed 2026-08-13 | $13.42M derived: sum of 3 quarters · filed 2026-08-13 | $18.08M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $8.00M 10-Q · filed 2026-05-14 | $8.00M derived: sum of 2 quarters · filed 2026-05-14 | $12.66M derived: sum of 3 quarters · filed 2026-05-14 | $12.63M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $4.66M derived: sum of 2 quarters · filed 2026-03-18 | $4.63M derived: sum of 3 quarters · filed 2026-03-18 | $4.63M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.63M derived: sum of 2 quarters · filed 2025-11-13 | $4.63M 10-Q · filed 2025-11-13 | $8.59M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$25.00K 10-Q · filed 2025-08-12 | $3.93M derived: sum of 3 quarters · filed 2025-08-12 | $3.93M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $3.96M derived: sum of 2 quarters · filed 2025-05-13 | $3.95M derived: sum of 3 quarters · filed 2025-05-13 | $4.00M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $3.95M derived: sum of 2 quarters · filed 2025-03-21 | $4.00M derived: sum of 3 quarters · filed 2025-03-21 | $4.14M 10-K · filed 2025-03-21 | $4.65M 10-K · filed 2024-03-22 |
| 2023-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $45.00K derived: sum of 2 quarters · filed 2024-11-08 | $186.00K 10-Q · filed 2024-11-08 | $186.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $190.00K 10-Q · filed 2024-08-13 | $190.00K derived: sum of 3 quarters · filed 2024-08-13 | $179.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $141.00K 10-Q · filed 2024-05-10 | $141.00K derived: sum of 2 quarters · filed 2024-05-10 | $130.00K derived: sum of 3 quarters · filed 2024-05-10 | $118.00K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$11.00K derived: sum of 2 quarters · filed 2024-03-22 | -$23.00K derived: sum of 3 quarters · filed 2024-03-22 | -$23.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$23.00K derived: sum of 2 quarters · filed 2023-11-13 | -$23.00K 10-Q · filed 2023-11-13 | -$23.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$12.00K 10-Q · filed 2023-08-10 | -$12.00K derived: sum of 3 quarters · filed 2023-08-10 | -$36.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | -$24.00K derived: sum of 3 quarters · filed 2023-05-10 | -$24.00K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$24.00K derived: sum of 2 quarters · filed 2023-03-22 | -$24.00K derived: sum of 3 quarters · filed 2023-03-22 | $74.72M 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$24.00K derived: sum of 2 quarters · filed 2022-11-10 | $74.72M 10-Q · filed 2022-11-10 | $80.21M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $74.75M 10-Q · filed 2022-08-12 | $80.23M derived: sum of 3 quarters · filed 2022-08-12 | $81.99M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $74.75M 10-Q · filed 2022-05-11 | $80.23M derived: sum of 2 quarters · filed 2022-05-11 | $81.99M derived: sum of 3 quarters · filed 2022-05-11 | $92.01M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $7.25M derived: sum of 2 quarters · filed 2022-03-24 | $17.26M derived: sum of 3 quarters · filed 2022-03-24 | $22.55M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $11.77M derived: sum of 2 quarters · filed 2021-11-10 | $17.07M 10-Q · filed 2021-11-10 | $17.07M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $10.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $15.30M 10-Q · filed 2021-08-11 | $15.30M derived: sum of 3 quarters · filed 2021-08-11 | $15.36M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $5.29M 10-Q · filed 2021-05-12 | $5.29M derived: sum of 2 quarters · filed 2021-05-12 | $5.34M derived: sum of 3 quarters · filed 2021-05-12 | $20.62M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $52.00K derived: sum of 2 quarters · filed 2021-03-24 | $15.33M derived: sum of 3 quarters · filed 2021-03-24 | $20.85M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $15.33M derived: sum of 2 quarters · filed 2020-11-12 | $20.85M 10-Q · filed 2020-11-12 | $22.61M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $15.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $20.80M 10-Q · filed 2020-08-12 | $22.56M derived: sum of 3 quarters · filed 2020-08-12 | $22.56M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | $5.52M 10-Q · filed 2020-05-11 | $7.28M derived: sum of 2 quarters · filed 2020-05-11 | $7.28M derived: sum of 3 quarters · filed 2020-05-11 | $9.35M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $1.76M derived: sum of 2 quarters · filed 2020-03-19 | $3.83M derived: sum of 3 quarters · filed 2020-03-19 | $12.04M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.07M derived: sum of 2 quarters · filed 2019-11-12 | $10.28M 10-Q · filed 2019-11-12 | $11.67M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | $10.28M 10-Q · filed 2019-08-16 | $11.67M derived: sum of 3 quarters · filed 2019-08-16 | $12.75M derived: sum of 4 quarters · filed 2019-08-16 | |
| 2018-03-31 | $8.21M 10-Q · filed 2019-05-13 | $9.60M derived: sum of 2 quarters · filed 2019-05-13 | $10.68M derived: sum of 3 quarters · filed 2019-05-13 | $13.01M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $2.47M derived: sum of 2 quarters · filed 2019-02-21 | $4.79M derived: sum of 3 quarters · filed 2019-02-21 | $10.06M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.41M derived: sum of 2 quarters · filed 2018-11-13 | $8.68M 10-Q · filed 2018-11-13 | $8.68M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $7.59M 10-Q · filed 2018-08-10 | $7.59M derived: sum of 3 quarters · filed 2018-08-10 | ||
| 2017-03-31 | $5.26M 10-Q · filed 2018-05-14 | $5.27M derived: sum of 2 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $8.87M 10-K · filed 2018-03-28 | |||
| 2016-09-30 | $8.86M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |